Low BMI May Contribute to Alzheimer's
Maintaining a weight that is overly thin can contribute to health problems in much the same way that being obese can. More recently a low body mass index has also been linked to early stages of Alzheimer's disease.
Boosting Memory in Alzheimer's Patients
Alzheimer's disease patients can have trouble remembering basics from the faces of loved ones to where they put something down. A medical food that has showed promise in trials could help with a memory boost.
Hypertension Drugs May Lower Alzheimer's Risk
Patients suffering from hypertension may be at an added benefit. Their blood pressure medication may help lower their risk of developing Alzheimer's disease.
Predicting Alzheimer's Disease
As seniors begin to age, many worry about the prospect of developing Alzheimer's disease. They may seek an evaluation, but it can be difficult to predict who is suffering from early symptoms even when memory problems are reported.
Healthy GPS Shoes
It's not uncommon for patients suffering from Alzheimer's disease to become confused and wander off. New shoes with built-in GPS systems may help ensure that seniors with dementia can be tracked and safely brought home.
Early Stages of Alzheimer's Categorized
Acknowledging that early stage Alzheimer's disease patients often do not yet have symptoms, Mayo Clinic researchers have proposed adding two pre-clinical stages to better classify patients.
Hysterectomy Raises Iron Levels and Risks
Iron is an essential element for a properly functioning body, but extemes of iron in the blood have different consequences. Strategies for optimizing iron levels are discussed in new research from the University of California - Los Angeles.
A New Target for Stroke and Alzheimer's Drugs
The discovery of key brain receptors gives researchers new ammunition in finding new and innovative ways to treat Alzheimer's disease and disability from stroke.
Blood Test May Indicate Alzheimer's Impact
For many Alzheimer's patients, the disease slowly erodes brain cognition. Others aren't so lucky and the decline can be rapid. The problem is there's been no way to identify those that quickly decline and need aggressive treatment.
Alzheimer's Medication Shows Promise
In a small preliminary study the drug gantenerumab appears to reduce amyloid levels in the brains of patients with Alzheimer's disease.